Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02369029
Title BAY1238097, First in Man
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

BAY 1238097

Age Groups: adult
Covered Countries USA | FRA | DEU


No variant requirements are available.